Monitor scientific publications and identify safety signals with traceable evidence.
Literature surveillance breaks at scale. Agentic AI is required to filter exponential data volumes and detect safety signals without exhausting scientific teams.
Teams must screen thousands of abstracts weekly from PubMed, Embase, and local journals. The sheer volume exceeds human capacity, leading to review backlogs.
Keyword-based search generates excessive irrelevant results (false positives). Reviewers waste hours discarding non-relevant articles instead of analyzing critical data.
Manual triage slows down the identification of Individual Case Safety Reports (ICSRs). Delays in detecting adverse events risk regulatory non-compliance and patient safety.
Critical insights are scattered across subscription databases, conference abstracts, and open-web sources. Aggregating these disparate formats for a unified view is manually intensive.
Redefining literature surveillance with Agentic AI – where signal detection meets automation, precision, and global coverage.
Reimagine pharmacovigilance with AI agents that work autonomously to ingest, deduplicate, and classify scientific literature across global databases. By understanding biomedical context rather than just keyword matching, the system intelligently distinguishes between valid safety signals, efficacy data, and irrelevant noise.
With built-in entity recognition, duplicate checking, and relevance scoring, achieve GVP-compliant accuracy and rapid screening cycles. Gain real-time visibility into emerging safety trends, competitive landscape, and therapeutic insights. Beyond automation, the system delivers intelligence by extracting Patient-Drug-Event relationships, highlighting Day 0 criteria, and surfacing actionable insights that strengthen safety monitoring and research strategy.
Extract adverse events, study designs, and competitive intelligence without manual reading. AI-driven accuracy that scales seamlessly with publication volumes.
reduction in manual screening effort
noise reduction in search results
compliance with search timelines
faster signal detection
Explore how literature sources are ingested, analyzed, and cross-referenced — turning unstructured publications into structured, traceable pharmacovigilance insights.
Access a complete audit trail of search strings, article disposition, and review decisions for regulatory inspections.
Auto-rank incoming articles by relevance and severity to ensure high-priority safety signals are reviewed first.
Expand monitoring to new therapeutic areas or local literature without increasing headcount or outsourcing costs.
Create a shared repository of validated scientific insights for PV, clinical development, and medical writing teams.




Find clarity on our solutions, capabilities, and how we can support your business.
Our platform is built to scale, efficiently managing high volumes of SOPs from multiple sources. Advanced algorithms and machine learning models adapt to various document formats and data types, ensuring consistent processing quality.
Botminds offers comprehensive support, including detailed documentation, training sessions, and dedicated customer service. We ensure that your team is well-equipped to use the platform effectively and maximize its benefits.
Absolutely! Botminds is designed to process various formats, including electronic documents, printed materials, and handwritten notes. Our flexible extraction models can seamlessly handle diverse data sources.
Book a 30-minute consultation to find the best starting point